DENVER, May 25, 2017 -- Centennial Resource Development, Inc. (the “Company”) (NASDAQ:CDEV) today announced that its stockholders have voted to approve the issuance of 26,100,000 shares of the Company’s Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), upon the conversion of 104,400 shares of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”), that were issued and sold to affiliates of Riverstone Investment Group LLC in private placements completed in December 2016. The proceeds of such private placements were used to fund a portion of the cash consideration for the Company’s acquisition of the leasehold interests and related upstream assets of Silverback Exploration, LLC and Silverback Operating, LLC. At a special meeting of the Company’s stockholders held earlier today, more than 99% of votes cast were in favor of approving the issuance of the shares of Class A Common Stock upon conversion of the shares of Series B Preferred Stock.
The final voting results will be disclosed in a Current Report on Form 8-K to be filed with the Securities and Exchange Commission later today.
About Centennial Resource Development, Inc.
Centennial Resource Development, Inc. is an independent oil and natural gas company focused on the development of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin. The Company’s assets and operations, which are held and conducted through Centennial Resource Production, LLC, are concentrated in the Delaware Basin, a sub-basin of the Permian Basin. For additional information about the Company, please visit www.cdevinc.com.
Contact: Hays Mabry Director, Investor Relations (832) 240-3265 [email protected]


US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 



